
Intracranial Aneurysm Market Report 2026
Global Outlook – By Treatment Approach (Endovascular Coiling, Surgical Clipping, Flow Diverters, Other Treatment Approaches), By Product Type (Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices, Access Devices), By End User (Hospitals, Specialty Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035
Intracranial Aneurysm Market Overview
• Intracranial Aneurysm market size has reached to $1.82 billion in 2025 • Expected to grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Rising Demand For Minimally Invasive Procedures Is Expected To Fuel The Growth Of The Intracranial Aneurysm Market. • Market Trend: Advanced Endovascular Innovations Enhance Management Of Complex Brain Aneurysms • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Intracranial Aneurysm Market?
An intracranial aneurysm refers to a localized, abnormal dilation or ballooning of a blood vessel within the brain. It is utilized when a blood vessel in the brain becomes weakened, usually due to a combination of genetic factors, high blood pressure, and other risk factors such as smoking or age. The main types of intracranial aneurysms are endovascular coiling, surgical clipping, flow diverters, and other types. Endovascular coiling refers to a minimally invasive procedure used to treat intracranial aneurysms. The various product types include aneurysm therapeutic devices, embolization devices, aspiration devices, and access devices and are used by various end users, such as hospitals, specialty clinics, and others.
What Is The Intracranial Aneurysm Market Size and Share 2026?
The intracranial aneurysm market size has grown rapidly in recent years. It will grow from $1.82 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing incidence of hypertension-related cerebrovascular disorders, advancements in neuroimaging technologies, limitations of conventional open brain surgeries, rising awareness of aneurysm rupture risks, expansion of neurosurgical and neurointerventional infrastructure.What Is The Intracranial Aneurysm Market Growth Forecast?
The intracranial aneurysm market size is expected to see rapid growth in the next few years. It will grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to growing aging population, increasing adoption of flow diverter devices, rising demand for early aneurysm screening, technological advancements in embolization devices, expanding investment in neurovascular research and innovation. Major trends in the forecast period include increasing preference for minimally invasive aneurysm treatments, rising adoption of endovascular coiling and flow diversion, growing focus on early detection and preventive intervention, expansion of advanced neurovascular treatment centers, improved clinical outcomes through multidisciplinary care.Global Intracranial Aneurysm Market Segmentation
1) By Treatment Approach: Endovascular Coiling, Surgical Clipping, Flow Diverters, Other Treatment Approaches 2) By Product Type: Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices, Access Devices 3) By End User: Hospitals, Specialty Clinics, Other End Users Subsegments: 1) By Endovascular Coiling: Soft Coils, Detachable Coils, Balloon-Assisted Coiling 2) By Surgical Clipping: Standard Surgical Clipping, Intraoperative Flow Diversion With Clipping 3) By Flow Diverters: Stent-Assisted Flow Diverters, Flow Diverter Devices For Complex Aneurysms 4) By Other Treatment Approaches: Intracranial Aneurysm Clipping With Bypass Surgery, Liquid Embolic AgentsWhat Is The Driver Of The Intracranial Aneurysm Market?
The rising demand for minimally invasive procedures is expected to fuel the growth of the intracranial aneurysm market. Minimally invasive procedures refer to medical interventions performed through small incisions or openings, reducing patient trauma and recovery time. The rising demand for minimally invasive procedures is due to their ability to offer shorter recovery times, reduced risks of complications, less pain, and smaller scars, making them more appealing to patients seeking quicker and safer treatment options. Intracranial aneurysm management has revolutionized minimally invasive procedures by enabling precise, targeted interventions that reduce patient recovery time and enhance overall surgical outcomes. For instance, in August 2023, according to The Aesthetic Society, a US-based organization of plastic surgery and cosmetic medicine, in 2023, Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase compared to the previous year. Moreover, in 2023, according to the American Society of Plastic Surgeons, a US-based specialty organization, the total number of cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Therefore, rising demand for minimally invasive procedures is expected to fuel the growth of the intracranial aneurysm industry.Key Players In The Global Intracranial Aneurysm Market
Major companies operating in the intracranial aneurysm market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, Phenox GmbH, Balt Group, Acandis GmbH & Co. KG, Codman Neuro, EndoStream Medical Ltd., Shape Memory Medical Inc., Evasc Neurovascular Enterprises ULCGlobal Intracranial Aneurysm Market Trends and Insights
Major companies operating in the intracranial aneurysm space are focusing on developing advanced solutions, such as next-generation flow diverters, to enhance device performance, improve vessel-wall apposition, and streamline deployment during endovascular procedures. A flow diverter refers to an implantable neurovascular device designed to redirect blood flow away from aneurysm sacs to promote healing, particularly in wide-neck or complex intracranial aneurysms. For instance, in July 2025, Stryker Corporation, a US-based medical technology company, launched the Surpass Elite Flow Diverter across the United States, South Korea, and Europe. Engineered with an upgraded implant architecture including a higher braid angle and optimized heat treatment the device delivers improved opening, enhanced vessel-wall apposition, and reduced manipulation during deployment. It also introduces the BioStealth Surface, a proprietary thromboresistant surface modification developed through a neutralization process, designed to reduce thrombin generation and support safer, more efficient flow-diversion procedures in complex aneurysm cases.What Are Latest Mergers And Acquisitions In The Intracranial Aneurysm Market?
In May 2023, Stryker Corporation, a US-based medical technology company, acquired Cerus Endovascular Limited for an undisclosed amount. Through this acquisition, Stryker Corporation aims to enhance its portfolio of neurointerventional devices for treating intracranial aneurysms, specifically through the addition of Cerus's CE-marked products such as the Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter, which address the growing need for one-and-done intrasaccular aneurysm therapy. Cerus Endovascular Limited is a US-based company that manufactures innovative medical devices for the treatment of intracranial aneurysms.Regional Outlook
North America was the largest region in the intracranial aneurysm market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Intracranial Aneurysm Market?
The intracranial aneurysm market consists of sales of flow diverter devices, embolization coils, neurovascular stents, intracranial balloons, aneurysm clips, and monitoring systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Intracranial Aneurysm Market Report 2026?
The intracranial aneurysm market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial aneurysm industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Intracranial Aneurysm Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.02 billion |
| Revenue Forecast In 2035 | $3.04 billion |
| Growth Rate | CAGR of 10.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Treatment Approach, Product Type, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, Phenox GmbH, Balt Group, Acandis GmbH & Co. KG, Codman Neuro, EndoStream Medical Ltd., Shape Memory Medical Inc., Evasc Neurovascular Enterprises ULC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
